Edition:
United States

Immune Pharmaceuticals Inc (IMNP.OQ)

IMNP.OQ on NASDAQ Stock Exchange Capital Market

0.25USD
18 May 2018
Change (% chg)

$0.00 (+0.60%)
Prev Close
$0.25
Open
$0.25
Day's High
$0.26
Day's Low
$0.24
Volume
196,718
Avg. Vol
214,415
52-wk High
$3.43
52-wk Low
$0.24

Chart for

About

Immune Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics in the fields of immuno-inflammation and immuno-oncology. The Company's segment is acquiring, developing and commercializing prescription drug products. Its... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $8.05
Shares Outstanding(Mil.): 31.90
Dividend: --
Yield (%): --

Financials

  IMNP.OQ Industry Sector
P/E (TTM): -- 28.57 32.53
EPS (TTM): -1.88 -- --
ROI: -158.24 13.08 12.63
ROE: -414.55 14.80 14.50

BRIEF-Immune Pharma Presents Positive Results From Phase 2 Trial Of Bullous Pemphigoid Treatment

* IMMUNE PHARMACEUTICALS PRESENTS UPDATED POSITIVE RESULTS FROM PHASE 2 TRIAL OF BERTILIMUMAB IN BULLOUS PEMPHIGOID

May 15 2018

BRIEF-Immune Pharmaceuticals Says Board Will Not Pursue Spin-Off Of Cytovia Unit

* IMMUNE PHARMACEUTICALS PROVIDES UPDATE ON PLANS FOR ONCOLOGY SUBSIDIARY, CYTOVIA, INC.

May 07 2018

Competitors

Earnings vs. Estimates